Skip to main content

Table 3 Treatment costs per cycle

From: Cost-effectiveness analysis of azacitidine in the treatment of high-risk myelodysplastic syndromes in Spain

 

Azacitidine

BSC

LDC

SDC

MDS treatment on treatment

€4,911.24

€1,426.21

€2,671.20

€20,853.08

Pre-medication

€0.70

€0

€2.11

€0

Treatment administration

€442.40

€0

€380.20

16,344.02

Pharmacology

€3,028.14

€0

€48.38

€790.41

Follow-up appointments

€238.55

€238.55

€238.55

€0*

Blood/Platelet transfusion

€926.07

€1,070.31

€1,754.35

€2,557.71

Concurrent Medication on treatment

€37.90

€54.72

€65.86

€87.21

Routine tests on treatment

€237.49

€62.63

€181.74

€1.073.74

MDS treatment off treatment

€1,627.78

€1,772.02

€2,456.06

€3,259.42

Follow-up appointments

€238.55

€238.55

€238.55

€238.55

Blood/Platelet transfusion

€926.07

€1,070.31

€1,754.35

€2,557.71

Concurrent Medication off treatment

€54.72

€54.72

€54.72

€54.72

Routine tests off treatment

€62.63

€62.63

€62.63

€62.63

Annualized Adverse Events BSC

€345.81

€345.81

€345.81

€345.81

Treatment administration BSC

€0

€0

€0

€0

AML treatment

€1,851.86

€1,851.86

€1,851.86

€1,851.86

Follow-up appointments

€233.33

€233.33

€233.33

€233.33

Adverse events

€345.81

€345.81

€345.81

€345.81

Concurrent Medication

€132.18

€132.18

€132.18

€132.18

Blood/Platelet transfusion

€1,070.31

€1,070.31

€1,070.31

€1,070.31

Routine tests

€70.24

€70.24

€70.24

€70.24

  1. Abbreviations: MDS = myelodysplastic syndrome; AML = acute myeloid leukaemia; BSC = best supportive care; LDC = low dose chemotherapy; SDC = standard dose chemotherapy.
  2. * Include only 1 chemotherapy session.